These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29854824)

  • 21. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
    Bessa SS; Hussein TA; Morad MA; Amer AM
    Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels and Clinical Significances of Glypican-5 in Urine of Type 2 Diabetic Nephropathy Cases.
    Li R; Zhang L; Zhang S; Yang H; Yao B; Dong W; Zhang B; Chen Y; Liu S; Zhao X; Zhang Q; Shi W; Liang X
    Iran J Kidney Dis; 2019 May; 13(3):173-181. PubMed ID: 31209190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
    Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
    J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD; Zheng M; Zhao LL; Qian Y; Yao XM; Ren A; Li SM; Jing CY
    Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary proteomics in diabetes and CKD.
    Rossing K; Mischak H; Dakna M; Zürbig P; Novak J; Julian BA; Good DM; Coon JJ; Tarnow L; Rossing P;
    J Am Soc Nephrol; 2008 Jul; 19(7):1283-90. PubMed ID: 18448586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.
    Sharma V; Tikoo K
    Mol Cell Biochem; 2014 Mar; 388(1-2):95-111. PubMed ID: 24281856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between methylation levels of targeted genes and albuminuria in patients with early diabetic kidney disease.
    Aldemir O; Turgut F; Gokce C
    Ren Fail; 2017 Nov; 39(1):597-601. PubMed ID: 28805547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.
    Ding X; Zhang D; Ren Q; Hu Y; Wang J; Hao J; Wang H; Zhao X; Wang X; Song C; Du J; Yang F; Zhu H
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients.
    Dihazi H; Müller GA; Lindner S; Meyer M; Asif AR; Oellerich M; Strutz F
    Clin Chem; 2007 Sep; 53(9):1636-45. PubMed ID: 17634209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
    Lee SY; Choi ME
    Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.
    Ruilope LM; Agarwal R; Chan JC; Cooper ME; Gansevoort RT; Haller H; Remuzzi G; Rossing P; Schmieder RE; Nowack C; Ferreira AC; Pieper A; Kimmeskamp-Kirschbaum N; Bakris GL
    Am J Nephrol; 2014; 40(6):572-81. PubMed ID: 25591469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes.
    Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K
    Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria.
    Oellgaard J; Gæde P; Persson F; Rossing P; Parving HH; Pedersen O
    J Diabetes Complications; 2018 Dec; 32(12):1133-1140. PubMed ID: 30282584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1.
    Meng L; Li G; Liu X; Jiang J; Zhu M; Sun Y
    Clin Lab; 2018 Jul; 64(7):1177-1182. PubMed ID: 30146830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher urinary IgM excretion in type 2 diabetic nephropathy compared to type 1 diabetic nephropathy.
    Bakoush O; Tencer J; Tapia J; Rippe B; Torffvit O
    Kidney Int; 2002 Jan; 61(1):203-8. PubMed ID: 11786102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
    Tang X; You J; Liu D; Xia M; He L; Liu H
    Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.